These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3934648

  • 21. Effects of thyrotropin-releasing hormone on myocardial adrenoceptors and dopaminergic receptors following hemorrhagic shock in the rat.
    Liu LM, Chen HS, Hu DY, Lu RQ, Li TX.
    Shock; 1995 Jun; 3(6):430-3. PubMed ID: 7656067
    [Abstract] [Full Text] [Related]

  • 22. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A, Rochester JA, Lefer AM.
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [Abstract] [Full Text] [Related]

  • 23. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat.
    Sirén AL, Powell E, Feuerstein G.
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1093-101. PubMed ID: 3087219
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
    Asai H, Watanabe Y, Yamauchi-Kohno R, Doi O.
    J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
    [Abstract] [Full Text] [Related]

  • 31. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE, Curtis MT, Jaffe JS, Lefer AM.
    Proc Soc Exp Biol Med; 1983 May; 173(1):76-81. PubMed ID: 6304745
    [Abstract] [Full Text] [Related]

  • 32. [Pharmacology of thyroliberin].
    Zakusov VV, Bulaev VM, Gan'shina TS, Kozhechkin SN, Mirzoian RS.
    Biull Eksp Biol Med; 1983 Sep; 96(9):61-4. PubMed ID: 6412782
    [Abstract] [Full Text] [Related]

  • 33. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D, Chen HS, Hu DY.
    Circ Shock; 1992 Mar; 36(3):169-73. PubMed ID: 1611701
    [Abstract] [Full Text] [Related]

  • 34. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK, Krishnamoorthy S, Pawar C, Kaur N, Monga V, Meena CL, Jain R, Sharma SS.
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [Abstract] [Full Text] [Related]

  • 39. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
    Holaday JW, Ruvio BA, Faden AI.
    Eur J Pharmacol; 1981 Aug 27; 74(1):101-5. PubMed ID: 6797829
    [Abstract] [Full Text] [Related]

  • 40. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar 27; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.